Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor.

Jin H, Yang Z, Wang J, Zhang S, Sun Y, Ding Y

National Center of Colorectal Surgery, The 3rd Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, 1 Jinling Road, Nanjing 210001, People's Republic of China. jinheiying@yahoo.com.cn

The orthotopic transplantation model of human tumor has been demonstrated to be more patient-like animal tumor model. However, observations of tumor progression and metastasis are limited by the deep location of the colon or limited deep penetration ability of fluorescence through tissue. The purpose of this study is to establish a superficial orthotopic model to allow easier real-time visualization and more sensitive monitoring of fluorescent orthotopic colon tumor. Human colon cancer HT-29 cells were transduced with a pLPCX expression retroviral vector containing green fluorescent protein and neomycin resistance genes. For superficial orthotopic transplantation model, the cecum was identified and pulled out of the peritoneal cavity, the space between the cecum and peritoneum was sutured, the cecum was pulled to subcutaneous tissue, and incision was made on the cecal serosa followed by the implantation of a 1-mm tumor tissue to the cecum. For comparison, a conventional orthotopic transplantation model was established in a separate group of mice simultaneously. When tumor sizes reached 5 mm in diameter, half the mice in each model received 5-FU treatment. Primary tumor and metastases were monitored by fluorescent imaging or caliber measurement. Tumor fluorescence was observed as early as 3 days (median time of 4.7 ± 1.3 days) post-transplantation in the superficial orthotopic transplantation model, which was much earlier than 21 days (median time of 26.2 ± 9.9 days) in conventional orthotopic transplantation model. Although tumor growth of 5-FU-treated mice in conventional orthotopic model was lower than those of the untreated mice, the difference was not significant. However, in superficial orthotopic model, tumor growth was significantly inhibited in 5-FU-treated mice relative to the untreated mice. Fluorescence imaging showed similar metastasis incidence between the superficial and conventional orthotopic transplantation models. The fluorescent superficial orthotopic transplantation colon model allows easier real-time visualization and more sensitive monitoring of tumor growth as well as convenient repeated sampling. It is a valuable orthotopic implantation model for study of colon cancer and evaluation of new anti-cancer therapy.

Published 21 February 2011 in Tumour Biol, 32(2): 391-7.
Full-text of this article is available online (may require subscription).

Articles on Colon Cancer published 21 February 2011:

O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.   Biochim Biophys Acta, 1812(4): 514-9.

O-GlcNAc is a monosaccharide attached to serine or threonine hydroxyl moieties on numerous nuclear and cytoplasmic proteins; O-GlcNAcylation is dynamically regulated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Although recent studies have shown that O-GlcNAcylation plays essential roles in breast cancer progression, it is also necessary to know whether O-GlcNAcylation is involved in other types of human cancer. In this study, O-GlcNAcylation levels and the expressions of OGT and OGA in ... [Abstract] [Full-text]

A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor.   Tumour Biol, 32(2): 391-7.

The orthotopic transplantation model of human tumor has been demonstrated to be more patient-like animal tumor model. However, observations of tumor progression and metastasis are limited by the deep location of the colon or limited deep penetration ability of fluorescence through tissue. The purpose of this study is to establish a superficial orthotopic model to allow easier real-time visualization and more sensitive monitoring of fluorescent orthotopic colon tumor. Human colon cancer HT-29 ... [Abstract] [Full-text]

Articles on Colon Cancer published 17 February 2011:

Modification of an in vitro model simulating the whole digestive process to investigate cellular endpoints of chemoprevention.   Br J Nutr, 105(5): 678-87.

In vitro gut fermentation systems are relevant tools to study health benefits of foodstuffs. Most of them are commonly used to investigate the degradation of nutrients or the development of gut flora. Using these models, strong cytotoxic effects of the resulting samples on cultured cells were observed. Hence, the aim of the present study was to develop a modified in vitro fermentation model that simulates the whole digestive tract and generates fermented samples that are suitable for testing in ... [Abstract] [Full-text]

Articles on Colon Cancer published 15 February 2011:

The Evi1, microRNA-143, K-Ras axis in colon cancer.   FEBS Lett, 585(4): 693-9.

MicroRNA profiling of diseased/non-diseased tissue has identified expression signatures associated with a wide range of pathogenic conditions including malignancy. For example, colon cancer is associated with the under expression of miRNA-143 yet the molecular etiology of under expression is unknown. The K-Ras oncogene is a target of miRNA-143. Here, we show that the ecotropic viral integration site 1 oncoprotein (Evi1) is a transcriptional suppressor of the miRNA-143 gene. We find an indirect ... [Abstract] [Full-text]

Articles on Colon Cancer published 9 February 2011:

Right colonic transposition technique: when the left colon is unavailable for achieving a pelvic anastomosis.   Dis Colon Rectum, 54(3): 360-2.

[Abstract] [Full-text]

Articles on Colon Cancer published 7 February 2011:

The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.   Gut, 60(3): 350-60.

[Abstract] [Full-text]

Articles on Colon Cancer published 31 January 2011:

The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.   Int J Cancer, 128(6): 1471-80.

Artemisinins are a class of compounds that are first-line treatment options for malaria. They also have potent antiproliferative activity, which makes them potential anticancer drugs. We have previously demonstrated anticancer activity of a number of these compounds in vitro; however, cytotoxic activities were compromised by drug-induced cell cycle arrests. In this study, we have explored further the activity of the clinical lead artemisinin-drug artesunate (ART), used either alone or in ... [Abstract] [Full-text]

β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.   Int J Cancer, 128(6): 1280-92.

Expression of the urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) has recently been shown to be directly regulated by the Wnt/β-catenin signaling pathway in colon cancer cells, through β-catenin binding to T-cell factor binding element motifs present in their gene promoters. In our study, we present evidence that inhibition of β-catenin causes upregulation of uPA/uPAR gene expression enhancing invasive potential. Using MCF-7, MDA-MB-231 (breast ... [Abstract] [Full-text]

© 2004-2011 Colon Cancer Research Today. All Rights Reserved.